A. Lievre, J. Bachet, V. Boige, A. Cayre, L. Corre et al., Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-379, 2008.
DOI : 10.1200/JCO.2007.12.5906

URL : https://hal.archives-ouvertes.fr/hal-00363737

G. Deng, I. Bell, S. Crawley, J. Gum, J. Terdiman et al., BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal Cancer, Clinical Cancer Research, vol.10, issue.1, pp.191-195, 2004.
DOI : 10.1158/1078-0432.CCR-1118-3

R. Corcoran, D. Dias-santagata, K. Bergethon, A. Iafrate, J. Settleman et al., BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation, Science Signaling, vol.3, issue.149, p.84, 2010.
DOI : 10.1126/scisignal.2001148

A. Lea, D. Allingham-hawkins, and S. Levine, BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer, PLoS Currents, vol.2, p.1187, 2010.
DOI : 10.1371/currents.RRN1187

M. Stroun, P. Anker, P. Maurice, J. Lyautey, C. Lederrey et al., Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients, Oncology, vol.46, issue.5, pp.318-322, 1989.
DOI : 10.1159/000226740

R. Mead, M. Duku, P. Bhandari, and C. Ia, Circulating tumour markers can define patients with normal colons, benign polyps and cancers, British Journal of Cancer, vol.53, issue.2, pp.239-245, 2011.
DOI : 10.1373/clinchem.2006.084509

A. Kamat, F. Bischoff, D. Dang, M. Baldwin, L. Han et al., Circulating cell-free DNA: A novel biomarker for response to therapy in ovarian carcinoma, Cancer Biology & Therapy, vol.5, issue.10, pp.1369-1374, 2006.
DOI : 10.4161/cbt.5.10.3240

URL : http://www.tandfonline.com/doi/pdf/10.4161/cbt.5.10.3240?needAccess=true

C. Rago, D. Huso, F. Diehl, B. Karim, G. Liu et al., Serial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA, Cancer Research, vol.67, issue.19, pp.9364-9370, 2007.
DOI : 10.1158/0008-5472.CAN-07-0605

H. Schwarzenbach, D. Hoon, and K. Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nature Reviews Cancer, vol.61, issue.83, pp.426-437, 2011.
DOI : 10.3322/caac.20107

E. Gormally, P. Hainaut, E. Caboux, L. Airoldi, H. Autrup et al., Amount of DNA in plasma and cancer risk: A prospective study, International Journal of Cancer, vol.84, issue.5, pp.746-749, 2004.
DOI : 10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.0.CO;2-J

M. Frattini, G. Gallino, S. Signoroni, D. Balestra, L. Lusa et al., Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer, Cancer Letters, vol.263, issue.2, pp.170-181, 2008.
DOI : 10.1016/j.canlet.2008.03.021

R. Leary, I. Kinde, F. Diehl, K. Schmidt, C. Clouser et al., Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing, Science Translational Medicine, vol.14, issue.9, pp.20-34, 2010.
DOI : 10.1038/nm.1789

URL : http://stm.sciencemag.org/content/scitransmed/2/20/20ra14.full.pdf

F. Diehl, M. Li, D. Dressman, Y. He, D. Shen et al., Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proceedings of the National Academy of Sciences, vol.315, issue.1-2, pp.16368-16373, 2005.
DOI : 10.1016/S0009-8981(01)00712-4

F. Diehl, K. Schmidt, M. Choti, K. Romans, S. Goodman et al., Circulating mutant DNA to assess tumor dynamics, Nature Medicine, vol.3, issue.9, pp.985-990, 2008.
DOI : 10.1136/jmg.36.10.730

URL : http://europepmc.org/articles/pmc2820391?pdf=render

F. Diehl, K. Schmidt, K. Durkee, K. Moore, S. Goodman et al., Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients, Gastroenterology, vol.135, issue.2, pp.489-498, 2008.
DOI : 10.1053/j.gastro.2008.05.039

M. Holdhoff, K. Schmidt, R. Donehower, L. Diaz, and . Jr, Analysis of Circulating Tumor DNA to Confirm Somatic KRAS Mutations, JNCI: Journal of the National Cancer Institute, vol.99, issue.3, pp.1284-1285, 2009.
DOI : 10.1038/sj.bjc.6604451

URL : https://academic.oup.com/jnci/article-pdf/101/18/1284/18614269/djp240.pdf

A. Thierry, F. Mouliere, C. Gongora, J. Ollier, B. Robert et al., Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Research, vol.70, issue.18, pp.6159-6175, 2010.
DOI : 10.1158/0008-5472.CAN-09-3513

URL : https://academic.oup.com/nar/article-pdf/38/18/6159/18784440/gkq421.pdf

F. Mouliere, B. Robert, A. Peyrotte, E. , D. Rio et al., High fragmentation characterizes tumourderived circulating DNA, PLoS One, vol.6, 2011.
DOI : 10.1371/journal.pone.0023418

URL : https://doi.org/10.1371/journal.pone.0023418

S. Bustin, V. Benes, J. Garson, J. Hellemans, J. Huggett et al., The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments, Clinical Chemistry, vol.55, issue.4, pp.611-622, 2009.
DOI : 10.1373/clinchem.2008.112797

URL : http://clinchem.aaccjnls.org/content/clinchem/55/4/611.full.pdf

J. Morlan, J. Baker, and D. Sinicropi, Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method, PLoS ONE, vol.26, issue.2, p.4584, 2009.
DOI : 10.1371/journal.pone.0004584.s003

URL : https://doi.org/10.1371/journal.pone.0004584

E. Lopez-crapez, L. Mineur, H. Emptas, and P. Lamy, KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?, British Journal of Cancer, vol.102, issue.6, pp.1074-1075, 2010.
DOI : 10.1373/49.6.853

URL : http://www.nature.com/bjc/journal/v102/n6/pdf/6605582a.pdf

K. Schmidt and F. Diehl, A blood-based DNA test for colorectal cancer screening, Discov Med, vol.7, pp.7-12, 2007.

J. Soh, N. Okumura, W. Lockwood, H. Yamamoto, H. Shigematsu et al., Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells, PLoS ONE, vol.1, issue.10, p.7464, 2009.
DOI : 10.1371/journal.pone.0007464.s011

URL : https://doi.org/10.1371/journal.pone.0007464

J. Choi, C. Reich, . Iii, and D. Pisetsky, The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells, Immunology, vol.273, issue.1, pp.55-62, 2005.
DOI : 10.1002/art.20254

D. Ota and B. Drewinko, Growth kinetics of human colorectal carcinoma, Cancer Res, vol.45, pp.2128-2131, 1985.

N. West, M. Dattani, P. Mcshane, G. Hutchins, J. Grabsch et al., The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients, British Journal of Cancer, vol.26, issue.10, pp.1519-1523, 2010.
DOI : 10.1016/j.humpath.2007.04.008

S. Jahr, H. Hentze, S. Englisch, D. Hardt, F. Fackelmayer et al., DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res, vol.61, pp.1659-1665, 2001.

U. Deligezer, N. Erten, E. Akisik, and N. Dalay, Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma, Experimental and Molecular Pathology, vol.80, issue.1, pp.72-76, 2006.
DOI : 10.1016/j.yexmp.2005.05.001

P. Gahan and M. Stroun, The virtosome-a novel cytosolic informative entity and intercellular messenger, Cell Biochemistry and Function, vol.95, issue.9, pp.529-538, 2010.
DOI : 10.3109/08820137309022799

K. Jung, M. Fleischhacker, and R. A. , Cell-free DNA in the blood as a solid tumor biomarker???A critical appraisal of the literature, Clinica Chimica Acta, vol.411, issue.21-22, pp.1611-1624, 2010.
DOI : 10.1016/j.cca.2010.07.032

J. Ellinger, V. Wittkamp, P. Albers, F. Perabo, S. Mueller et al., Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer, The Journal of Urology, vol.181, issue.1, pp.363-371, 2009.
DOI : 10.1016/j.juro.2008.08.118